Search details
1.
Prevalent new user designs: A literature review of current implementation practice.
Pharmacoepidemiol Drug Saf
; 32(11): 1252-1260, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37309989
2.
Severity of Severe Acute Respiratory System Coronavirus 2 (SARS-CoV-2) Alpha Variant (B.1.1.7) in England.
Clin Infect Dis
; 75(1): e1120-e1127, 2022 08 24.
Article
in English
| MEDLINE | ID: mdl-34487522
3.
Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY.
BMC Med
; 20(1): 243, 2022 07 05.
Article
in English
| MEDLINE | ID: mdl-35791013
4.
Transparency of high-dimensional propensity score analyses: Guidance for diagnostics and reporting.
Pharmacoepidemiol Drug Saf
; 31(4): 411-423, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35092316
5.
Proton pump inhibitors and risk of all-cause and cause-specific mortality: A cohort study.
Br J Clin Pharmacol
; 87(8): 3150-3161, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33393677
6.
Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February.
Euro Surveill
; 26(11)2021 03.
Article
in English
| MEDLINE | ID: mdl-33739254
7.
Implementing high-dimensional propensity score principles to improve confounder adjustment in UK electronic health records.
Pharmacoepidemiol Drug Saf
; 29(11): 1373-1381, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32926504
8.
NHS National Data Opt-Outs: trends and potential consequences for health data research.
BJGP Open
; 2024 Mar 04.
Article
in English
| MEDLINE | ID: mdl-38438199
9.
Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT).
Lancet Reg Health Eur
; 40: 100908, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38689605
10.
Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study.
Lancet Reg Health Eur
; : 100636, 2023 May 03.
Article
in English
| MEDLINE | ID: mdl-37363796
11.
Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study.
BMJ Open
; 13(1): e066164, 2023 01 31.
Article
in English
| MEDLINE | ID: mdl-36720568
12.
Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platform.
EClinicalMedicine
; 61: 102077, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-37434746
13.
Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in patients on kidney replacement therapy: observational study using the OpenSAFELY-UKRR and SRR databases.
Clin Kidney J
; 16(11): 2048-2058, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37915915
14.
Comparative effectiveness of nirmatrelvir/ritonavir versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised high-risk patients during Omicron waves: observational cohort study using the OpenSAFELY platform.
Lancet Reg Health Eur
; 34: 100741, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37927438
15.
Living alone and mental health: parallel analyses in UK longitudinal population surveys and electronic health records prior to and during the COVID-19 pandemic.
BMJ Ment Health
; 26(1)2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37562853
16.
Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY.
BMJ Med
; 2(1): e000276, 2023.
Article
in English
| MEDLINE | ID: mdl-36936265
17.
Survival Outcomes and Prognostic Factors in Glioblastoma.
Cancers (Basel)
; 14(13)2022 Jun 28.
Article
in English
| MEDLINE | ID: mdl-35804940
18.
OpenSAFELY: Representativeness of electronic health record platform OpenSAFELY-TPP data compared to the population of England.
Wellcome Open Res
; 7: 191, 2022.
Article
in English
| MEDLINE | ID: mdl-35966958
19.
Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform.
BMJ
; 379: e071932, 2022 11 16.
Article
in English
| MEDLINE | ID: mdl-36384890
20.
Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform.
Vaccine
; 40(32): 4479-4487, 2022 07 30.
Article
in English
| MEDLINE | ID: mdl-35715350